Functional assays for identifying ligands at orphan G protein-coupled receptors

• Published in: Receptors & channels Vol. 8; no. 5-6; pp. 297 - 308
• Main Author: Szekeres, Philip G
• Format: Journal Article
• Language: English
• Published: England 01.01.2002
• Subjects: Animals; Arachidonic Acid - metabolism; Biochemistry - methods; Biotechnology - methods; Calcium - metabolism; Cyclic AMP - metabolism; Electrophysiology; Endocytosis; Green Fluorescent Proteins; GTP-Binding Proteins - chemistry; GTP-Binding Proteins - metabolism; Humans; Ligands; Luminescent Proteins - metabolism; Models, Biological; Peptides - chemistry; Receptors, Cell Surface - chemistry; Receptors, Cell Surface - metabolism; Saccharomyces cerevisiae - metabolism; Xenopus laevis
• ISSN: 1060-6823
• DOI: 10.1080/10606820214642

The superfamily of G protein-coupled receptors (GPCRs; 7TMs) is one of the largest families of genes identified in humans, and has a proven history of being an excellent source of drug targets. The near completion of the human genome sequencing project has allowed the identification of a plethora of sequences encoding "orphan" GPCRs--putative receptors whose natural ligand(s) remain to be discovered. In many cases, the level of sequence homology with known receptors is insufficient to be able to predict the natural ligand for these orphan receptors, although it is usually possible to determine the likely nature of the cognate ligand e.g. peptide, lipid, nucleotide etc. Deorphanizing these novel GPCRs and evaluating their biological function has become a major target of many of the major pharmaceutical companies as well as several academic groups. Since 1995 more than 50 ligands for orphan GPCRs have been discovered by using the orphan receptor as a biosensor and screening candidate compounds looking for a biological response (the so-called "reverse pharmacology" approach). Identification of the natural ligands for these receptors marks the beginning of the process of understanding the biology of these newly discovered signalling systems and the development of novel therapies targeted at them. This article will focus on the functional assays which have been used to discover ligands for orphan GPCRs.